Gene · 57510
XPO5: exportin 5
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. XPO5: exportin 5. Genes, record 57510. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/57510
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9HAV4 | Exportin-5 | 1,204 | 3 | Ensembl, GeneID, HGNC |
Source UniProt
Patents29
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4802068 A1 | 2026-09-09 | 6 | Q9HAV4 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 45662 | Q9HAV4 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 2469 | Q9HAV4 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 2055 | Q9HAV4 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 4594 | Q9HAV4 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 2055 | Q9HAV4 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 2469 | Q9HAV4 | Espacenet |
| KR 1020250017231 A | 2025-02-04 | 4594 | Q9HAV4 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 29209 | Q9HAV4 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 132180 | Q9HAV4 | Espacenet |
1 to 10 of 29
See all 29 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants2,103
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | XPO5 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 17 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 11 | 2025 |
| P30CA033572 | Cancer Center Support Grant | 9 | 2025 |
| P50CA127001 | SPORE in Brain Cancer | 9 | 2025 |
| P30CA060553 | The Robert H. Lurie Comprehensive Cancer Center | 8 | 2025 |
| P30CA016056 | Roswell Park Cancer Center Support Grant | 6 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 5 | 2025 |
| R01CA225958 | Novel bioengineered microRNA therapeutics for lung cancer | 5 | 2025 |
| R01GM083300 | Selective regulatory and biogenesis mechanisms for microRNAs | 5 | 2025 |
| ZIAAG000393 | Influence of Post-transcriptional Gene Regulation on Cell Senescence and Aging | 5 | 2025 |
1 to 10 of 2,103Source NIH's project files
See all 2,103 nih grantsPapers3,895
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Acute and Chronic High-Intensity Exercise Differentially Regulate the miRNA Biogenesis Pathway in Human Skeletal Muscle. | Genes (Basel) | 2026 | 42353784 | PubTator, text mining | PubMed |
| PymiRa: A rapid and accurate classification tool for small non-coding RNAs, including microRNAs. | PLoS Comput Biol | 2026 | 41886518 | PubTator, text mining | PubMed |
| Dysregulation of SIRT1, polyamines and miRNA editing in cancer and aging. | Amino Acids | 2026 | 41863647 | PubTator, text mining | PubMed |
| Advances in the biological functions of miR‑205 in various diseases (Review). | Mol Med Rep | 2026 | 41860043 | PubTator, text mining | PubMed |
| Crosstalk between KRAS and miRNAs in pancreatic cancer: Opportunities for its diagnosis, prognosis and therapeutic intervention (Review). | Int J Oncol | 2026 | 41860028 | PubTator, text mining | PubMed |
| Tumor Suppressor p53 and MicroRNAs Interaction in Breast Cancer. | Oncol Res | 2026 | 41799525 | PubTator, text mining | PubMed |
| X chromosome-encoded microRNAs in immune regulation: sex differences and clinical implications. | Front Glob Womens Health | 2026 | 41799158 | PubTator, text mining | PubMed |
| Assessing the contributions of noncoding RNAs in acute myeloid leukemia. | Blood Neoplasia | 2026 | 41798679 | PubTator, text mining | PubMed |
| Exploring the role of microRNA-155 as a biomarker and regulatory modulator of target genes in metabolic syndrome. | SAGE Open Med | 2026 | 41777416 | PubTator, text mining | PubMed |
| RNA Regulatory Networks: Key Hubs in the Panorama of Cancer and Emerging Therapeutic Targets. | MedComm (2020) | 2026 | 41756253 | PubTator, text mining | PubMed |
1 to 10 of 3,895
See all 3,895 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/57510
GET https://conductscience.org/api/genes/v1/57510/patents?page=2